Sensoriis, Inc

Modus Health LLC, based in Edmonds, WA, specializes in providing innovative solutions for clinical trials, clinical care, and academic research. The company offers a range of products, including the StepWatch system, designed to gather real-time data for various applications. For clinical trials, Modus Health's Clinical Trial Research system enables real-time data collection through the CR Site app and Companion app for remote data uploads. The system features customizable setups, data formats, and a dashboard for data review. Additionally, the company provides training, program management, and data cleaning services tailored to the study's needs. In the realm of clinical care, the Clinical Care system is utilized by clinics and hospitals to enhance patient mobility through high-intensity gait training. With features like the CC Clinician app and Companion app, the system aids in monitoring patient progress and providing necessary assistance. Modus Health offers training for staff as part of the package, with pricing based on the number of patients utilizing the system annually. Generated from the website content

Kurve Technology, Inc., based in Lynnwood, WA, is dedicated to addressing unmet clinical needs for patients suffering from chronic sinusitis and complex Central Nervous System (CNS) disorders. Their innovative medical technology aims to provide hope for millions battling neurodegenerative diseases like Alzheimer's through non-invasive and effective treatment options. With a mission focused on enhancing clinical outcomes, Kurve Technology is committed to developing next-generation therapies that offer simpler solutions for patients in need. The company strives to improve the quality of life for those affected by debilitating conditions while advancing clinical development in the field of systemic and CNS therapies. Generated from the website

ID Genomics SPC, based in Seattle, WA, specializes in personalized diagnostics for infectious diseases, focusing on enhancing patient outcomes through precise antibiotic matching. Their innovative products, like CLoNeT, use rapid molecular diagnostics combined with extensive epidemiological surveillance to tackle the pressing issue of antibiotic resistance, particularly in urinary tract infections. The company offers a range of services, including microbial identification and genomic analysis, along with advanced methods for testing antibiotic susceptibility and monitoring pathogens such as SARS-CoV-2. Their commitment to leveraging big-data strategies and proprietary technologies positions them at the forefront of infectious disease management and treatment optimization. Generated from the website